Pfizer 2013 Annual Report Download - page 25

Download and view the complete annual report

Please find page 25 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Financial Review
Pfizer Inc. and Subsidiary Companies
24
2013 Financial Report
Revenues—Major Biopharmaceutical Products
The following table provides revenue information for several of our major biopharmaceutical products:
(MILLIONS OF DOLLARS) Year Ended December 31, % Change
PRODUCT PRIMARY INDICATIONS 2013 2012 2011 13/12 12/11
Lyrica Epilepsy, post-herpetic neuralgia and diabetic peripheral neuropathy,
fibromyalgia and neuropathic pain due to spinal cord injury
$ 4,595 $ 4,158 $ 3,693 11 13
Prevnar family Vaccine for prevention of pneumococcal disease 3,974 4,117 4,145 (3) (1)
Enbrel (Outside the
U.S. and Canada)
Rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque
psoriasis and ankylosing spondylitis
3,774 3,737 3,666 12
Celebrex Arthritis pain and inflammation, acute pain 2,918 2,719 2,523 78
Lipitor Reduction of LDL cholesterol 2,315 3,948 9,577 (41) (59)
Viagra Erectile dysfunction 1,881 2,051 1,981 (8) 4
Zyvox Bacterial infections 1,353 1,345 1,283 15
Norvasc Hypertension 1,229 1,349 1,445 (9) (7)
Sutent Advanced and/or metastatic renal cell carcinoma (mRCC), refractory
gastrointestinal stromal tumors (GIST) and advanced pancreatic
neuroendocrine tumor
1,204 1,236 1,187 (3) 4
Premarin family Menopause 1,092 1,073 1,013 26
BeneFIX Hemophilia 832 775 693 712
Vfend Fungal infections 775 754 747 31
Genotropin Replacement of human growth hormone 772 832 889 (7) (6)
Pristiq Depression 698 630 577 11 9
Chantix/Champix An aid to smoking cessation treatment 648 670 720 (3) (7)
Refacto AF/Xyntha Hemophilia 602 584 506 315
Xalatan/Xalacom Glaucoma and ocular hypertension 589 806 1,250 (27) (36)
Detrol/Detrol LA Overactive bladder 562 761 883 (26) (14)
Zoloft Depression and certain anxiety disorders 469 541 573 (13) (6)
Medrol Inflammation 464 523 510 (11) 3
Effexor Depression and certain anxiety disorders 440 425 678 4(37)
Zosyn/Tazocin Antibiotic 395 484 636 (18) (24)
Zithromax/Zmax Bacterial infections 387 435 453 (11) (4)
Fragmin Anticoagulant 359 381 382 (6) —
Relpax Treats the symptoms of migraine headache 359 368 341 (2) 8
Tygacil Antibiotic 358 335 298 712
Rapamune Immunosuppressant 350 346 372 1(7)
Inlyta Advanced renal cell carcinoma (RCC) 319 100 — **
Sulperazon Antibiotic 309 262 218 18 20
Revatio Pulmonary arterial hypertension (PAH) 307 534 535 (43) —
Cardura Hypertension/Benign prostatic hyperplasia 296 338 380 (12) (11)
Xalkori Anaplastic lymphoma kinase positive non-small cell lung cancer 282 123 16 129 *
Xanax/Xanax XR Anxiety disorders 276 274 306 1(10)
Diflucan Fungal infections 242 259 265 (7) (2)
Toviaz Overactive bladder 236 207 187 14 11
Aricept(a) Alzheimer's disease 235 326 450 (28) (28)
Inspra High blood pressure 233 214 195 910
Caduet Reduction of LDL cholesterol and hypertension 223 258 538 (14) (52)
Somavert Acromegaly 217 197 183 10 8
Neurontin Seizures 216 235 289 (8) (19)
Unasyn Injectable antibacterial 212 228 231 (7) (1)
BMP2 Development of bone and cartilage 209 263 340 (21) (23)
Geodon Bipolar disorder 194 353 1,022 (45) (65)
Depo-Provera Contraceptive 191 148 139 29 6
Aromasin Breast cancer 185 210 361 (12) (42)
Xeljanz Rheumatoid arthritis 114 6—**
Alliance revenues(b) Various 2,628 3,492 3,630 (25) (4)
All other Various 7,360 7,804 7,441 (6) 5
(a) Represents direct sales under license agreement with Eisai Co., Ltd.
(b) Includes Enbrel (in the U.S. and Canada through October 31, 2013), Spiriva, Rebif, Aricept and Eliquis.
* Calculation not meaningful.
Certain amounts and percentages may reflect rounding adjustments.